Shattuck Labs Ownership | Who Owns Shattuck Labs?
Shattuck Labs Ownership Summary
Shattuck Labs is owned by 80.46% institutional investors, 5.09% insiders, and 14.45% retail investors. T. rowe price investment management is the largest institutional shareholder, holding 14.18% of STTK shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.65% of its assets in Shattuck Labs shares.
STTK Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Shattuck Labs | 80.46% | 5.09% | 14.45% |
| Sector | Healthcare Stocks | 35.75% | 11.89% | 52.37% |
| Industry | Biotech Stocks | 36.05% | 11.82% | 52.13% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| T. rowe price investment management | 9.87M | 14.18% | $63.44M |
| Orbimed advisors | 6.31M | 9.06% | $40.55M |
| Redmile group | 5.54M | 7.96% | $35.62M |
| Prosight management, lp | 5.00M | 7.19% | $32.18M |
| Adage capital partners gp | 4.64M | 6.68% | $29.87M |
| Blackrock | 2.47M | 4.89% | $9.55M |
| Vanguard group | 2.38M | 3.29% | $8.68M |
| Price t rowe associates inc /md/ | 1.78M | 2.56% | $11.46M |
| Clark estates inc/ny | 1.48M | 2.12% | $9.49M |
| Pinnacle associates | 1.37M | 1.97% | $8.80M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Takeda pharmaceutical | 515.62K | 7.53% | $1.23M |
| Prosight management, lp | 5.00M | 5.28% | $32.18M |
| Redmile group | 5.54M | 2.36% | $35.62M |
| Clark estates inc/ny | 1.48M | 2.28% | $9.49M |
| Orbimed advisors | 6.31M | 0.81% | $40.55M |
| Diadema partners lp | 293.66K | 0.32% | $1.89M |
| Lbj family wealth advisors | 82.18K | 0.29% | $490.00K |
| Sphera funds management | 280.79K | 0.29% | $1.81M |
| 683 capital management | 800.00K | 0.27% | $5.14M |
| Piper sandler | 39.47K | 0.25% | $253.77K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| T. rowe price investment management | 9.87M | 0.04% | 8.51M |
| Prosight management, lp | 5.00M | 5.28% | 2.62M |
| Blackrock | 2.47M | 0.00% | 1.94M |
| Ameriprise financial | 905.71K | 0.00% | 894.21K |
| Abrdn | 1.16M | 0.01% | 628.14K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Adage capital partners gp | 4.64M | 0.05% | -1.66M |
| Franklin resources | - | - | -1.57M |
| Laurion capital management lp | - | - | -661.04K |
| 683 capital management | 800.00K | 0.27% | -590.00K |
| Price t rowe associates inc /md/ | 1.78M | 0.00% | -143.35K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vanguard fiduciary trust | 324.59K | 0.00% | 324.59K | $2.09M |
| Diadema partners lp | 293.66K | 0.32% | 293.66K | $1.89M |
| Algert global | 286.07K | 0.03% | 286.07K | $1.84M |
| Hudson bay capital management lp | 228.82K | 0.01% | 228.82K | $1.47M |
| Deutsche bank ag\ | 194.77K | 0.00% | 194.77K | $1.25M |
Sold Out
| Holder | Change |
|---|---|
| Advisor group | -6.00 |
| Srs capital advisors | -14.00 |
| True wealth design | -46.00 |
| Eversource wealth advisors | -112.00 |
| Federated hermes | -152.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 82 | 30.16% | 55,990,184 | 33.22% | 80 | 2.37% | 57 | 62.86% | 12 | 9.09% |
| Dec 31, 2025 | 21 | -62.50% | 6,167,506 | -83.05% | 8 | 0.17% | 11 | -60.71% | 4 | -80.00% |
| Sep 30, 2025 | 16 | -71.93% | 4,882,311 | -82.75% | 9 | 0.31% | 6 | -78.57% | 6 | -68.42% |
| Jun 30, 2025 | 61 | -18.67% | 28,684,223 | -8.03% | 56 | 1.50% | 30 | 20.00% | 21 | -12.50% |
| Mar 31, 2025 | 5 | -93.24% | 12,594,508 | -60.18% | 24 | 0.64% | 2 | -94.87% | 1 | -94.44% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 2.22M | 4.65% | 12.22K |
| Fidelity Growth Compy Commingled Pl O | 2.21M | 4.63% | - |
| T. Rowe Price Small-Cap Value | 2.83M | 4.47% | -1.76K |
| T. Rowe Price Small-Cap Stock | 2.02M | 3.19% | -1.44K |
| Fidelity Advisor Biotechnology I | 1.32M | 2.76% | - |
| Vanguard US Total Market Shares ETF | 1.31M | 2.74% | - |
| Fidelity Growth Company Fund | 1.28M | 2.68% | -2.72K |
| T. Rowe Price US Small-Cap Core Equity | 2.02M | 2.68% | 2.02M |
| T. Rowe Price U.S. SC Value Eq Tr-D | 1.84M | 2.44% | 1.34M |
| Franklin Biotechnology Discv A(acc)USD | 1.06M | 2.23% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 01, 2026 | Shukla Abhinav A. | Chief Technical Officer | Sell | $707.00 |
| Jun 30, 2026 | Shukla Abhinav A. | Chief Technical Officer | Sell | $165.42K |
| Jun 30, 2026 | Pandite Arundathy N. | Chief Medical Officer | Sell | $210.30K |
| Jun 11, 2026 | Ashiya Mona | - | Buy | $104.17 |
| Jun 11, 2026 | Ashiya Mona | - | Buy | $20.83 |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 1 |
| 2026 Q2 | 5 | 4 |
| 2026 Q1 | - | - |
| 2025 Q3 | 12 | - |
| 2025 Q1 | - | - |
STTK Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools